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Abstract
Behavioral endophenotypes are determined by a multitude of counteracting but precisely balanced molecular and
physiological mechanisms. In this study, we aim to identify potential novel molecular targets that contribute to the
multigenic trait ‘‘anxiety’’. We used microarrays to investigate the gene expression profiles of different brain regions within
the limbic system of mice which were selectively bred for either high (HAB) or low (LAB) anxiety-related behavior, and also
show signs of comorbid depression-like behavior. We identified and confirmed sex-independent differences in the basal
expression of 13 candidate genes, using tissue from the entire brain, including coronin 7 (Coro7), cathepsin B (Ctsb),
muscleblind-like 1 (Mbnl1), metallothionein 1 (Mt1), solute carrier family 25 member 17 (Slc25a17), tribbles homolog 2
(Trib2), zinc finger protein 672 (Zfp672), syntaxin 3 (Stx3), ATP-binding cassette, sub-family A member 2 (Abca2),
ectonucleotide pyrophosphatase/phosphodiesterase 5 (Enpp5), high mobility group nucleosomal binding domain 3
(Hmgn3) and pyruvate dehydrogenase beta (Pdhb). Additionally, we confirmed brain region-specific differences in the
expression of synaptotagmin 4 (Syt4). Our identification of about 90 polymorphisms in Ctsb suggested that this gene might
play a critical role in shaping our mouse model’s behavioral endophenotypes. Indeed, the assessment of anxiety-related and
depression-like behaviors of Ctsb knock-out mice revealed an increase in depression-like behavior in females. Altogether,
our results suggest that Ctsb has significant effects on emotionality, irrespective of the tested mouse strain, making it a
promising target for future pharmacotherapy.
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Introduction
Most behavioral patterns are shaped by both genetic and
environmental influences. Genetic factors first determine a set but
flexible framework, and then environmental influences fix the
respective behavior within the genetically given constraints. These
two influences appear to be the most important actors in the
developmental process. Thus, some of us are predisposed to never
develop any kind of psychiatric disorder, whereas others might
succumb from only minor external stimuli [1,2,3].
Multiple mechanisms that increase anxiety have evolved in the
animal kingdom [4]. Since these systems are very old in
evolutionary terms, many other molecular systems have since
evolved to control anxiety, closely connected stress-induced
physiological responses, and to re-establish a homeostatic state
afterwards. Twin studies of anxiety and depression enable
scientists to estimate the heritability of psychiatric disorders, with
estimates for the heritability of major depression and phobia
spectrum disorders ranging from 28 to 60%. These studies also
show increased prevalence of these disorders within some families,
while others are completely unaffected [5,6,7,8]. Since approxi-
mately 40% of the population of industrialized countries is at risk
to develop some kind of anxiety or mood disorder [9], the costs of
treatment and economic losses caused by these disorders are large
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and steadily increasing. The mechanisms underlying the etiology
of these disorders are not well characterized, and the efficacy of
current therapies is not high enough to result in full recovery of
many patients. These facts underline the urgent need for new,
more effective therapeutic methods with fewer side effects.
Since psychiatric and behavioral traits are linked to a wide
variety of genomic regions, with each region contributing less than
10% to the total phenotypic variation (quantitative trait locus), it is
important to screen a large number of loci to reveal the impact of a
single genomic locus. The key problem of quantitative trait locus
analysis for complex psychiatric disorders is that, in most cases,
linkage or association studies deal with rather small effect sizes that
are difficult to reproduce in human studies, and low marker
densities are common in animal studies [10,11,12]. For the latter,
the identified regions may contain many genes, and finer mapping
usually requires a large expenditure of time and money.
One alternative approach that can still identify the genes
involved in shaping a specific phenotype is gene expression
profiling. Since current technology cannot characterize patients by
the molecular biological processes in their brains, the best way to
explore these mechanisms is through animal models. Since the
exonic genome parts of rodents are approximately 92% homol-
ogous to those of humans, rodents with their short reproduction
time are prime candidates for use in these models [13,14].
The high (HAB) and low (LAB) anxiety-related behavior mouse
model, used to analyze the traits of anxiety and depression, has been
well described and characterized. It has also been validated in a
variety of behavioral tests, which assess both anxiety-related (such as
elevated plus-maze – EPM, light/dark box test, ultra sonic
vocalization – USV) and depression-like (tail-suspension test –
TST, forced swimming test – FST) behaviors. As a further
validation, the administration of diazepam results in a decrease in
measured anxiety-related behavior in the USV in HAB, but not
LAB, mice [14,15]. Some genes have already been proposed as
contributors to the observed phenotypes in this model, including
arginine vasopressin-neurophysin II-copeptin (Avp), which is
significantly less expressed in LAB mice compared to HAB and
wildtype CD-1 mice. Importantly, LABmice have been identified as
carrying a single-nucleotide polymorphism homozygously in the Avp
gene, as well as a deletion of 12 bp in the promoter region. Either of
these could lead to a reduction in gene expression or mRNA
processing, resulting in a decreased amount of the peptide, and
ultimately causing a 50% reduction in bioactive AVP and a non-
grave variant of familial diabetes insipidus [16,17]. Similar findings
also exist for glyoxalase 1 (Glo1), enolase phosphatase (Enoph1) and
the transmembrane protein 132 D (Tmem132d) [15,18,19,20].
Thus, the HAB/LAB model, with its strongly genetically fixed
background, is ideal for deeper molecular characterization. As
identification of differential gene and protein expression between
both lines has revealed more gene sequence-based differences [19],
a comprehensive screening on gene expression had become more
important. Therefore, we focused on the emotion-regulating parts
of the limbic system and the brain regions closely connected to
them: the hypothalamic paraventricular nucleus (PVN), the
supraoptic nucleus (SON), the basolateral (BLA) and central
(CeA) amygdala, and the cingulate cortex (Cg), as well as the
nucleus accumbens (NAc) and dentate gyrus (DG). Our previous
results support the hypothesis that these regions are critical in
producing the respective endophenotypes in HAB/LAB mice [21].
To gain insight into differences at the gene expression level that
could underlie the observed anxiety-related endophenotypes, we
conducted a comprehensive overview of gene expression in these
brain regions, utilizing the MPIP24k microarray and the Mou-
seWG-6 v1.1 Expression BeadChip-system (Illumina, San Diego,
CA), which provided information from about 45,000 unique probes.
As gene expression data from microarray analyses are generally not
seen as being stably reproducible, these results were further
confirmed by quantitative polymerase chain reaction (qPCR), and
partial confirmation was obtained by in situ hybridization analyses.
We further expanded our analyses by looking at the underlying
DNA sequences, and finally characterized a knock-out (KO) mouse
for Cathepsin B (Ctsb), the candidate gene that showed the most
prominent variations throughout our data.
Results
Microarray, qPCR and in situ hybridization
In a negative control experiment, hybridizing identical dye-
swapped samples from the MPIP24k arrays did not return a single
statistically significant result. From all MPIP24k and Illumina
platform-based microarray experiments, we found over 300
candidate genes which were differentially regulated between
HAB and LAB mice in all analyzed brain regions. All data are
available in the NCBI GEO database under the accession number
GSE29015. From these, the top 32 candidates were investigated in
the follow-up qPCR experiment and other analyses (Table S1,
excerpt Fig. 1B). In every experiment (that is, throughout all brain
regions), ATP-binding cassette, sub-family A member 2 (Abca2),
Ctsb, ectonucleotide pyrophosphatase/phosphodiesterase 5
(Enpp5), and tau tubulin kinase 1 (Ttbk1) displayed the largest
difference in regulation between lines (.500%). Other genes also
attracted our attention, like transthyretin (Ttr) in the BLA and
synaptotagmin 4 (Syt4) in the PVN, CeA and BLA. These were
oppositely regulated between our two lines, but only in single brain
regions. However, we focused on the other genes for this study, as
we hypothesized that changes in regulation between most brain
regions are more likely to represent general systemic changes, and
are therefore more likely to be associated with changes in the
phenotypes under consideration. We were able to confirm
differences in gene regulation for 13 of the selected genes, by
using qPCR on mRNA from the entire brain, with twelve of the
candidates delivering statistically significant results (p,0.05;
Figure 1A). Although the results for syntaxin 3 (Stx3) showed an
opposite effect in the microarray experiments (higher in HAB than
in LAB mice) compared to the qPCR, we can rely on the data of
the qPCR, as the qPCR data has been replicated a second time
with independent samples from the BLA (Fig. 2A). The relatively
high number of SNPs detected in the 15th exon of Stx3 (Table S2)
could also explain the higher affinity of Stx3 probes for the HAB-
specific mRNA in the microarray experiment. For most genes, the
difference in regulation is independent of sex, as the microarray
analyses were performed with male mice, and the validation by
qPCR was performed with male mice as well as female mice.
Thus, for the genes coronin 7 (Coro7), Ctsb, muscleblind-like 1
(Mbnl1), matrix metallopeptidase 15 (Mmp15), Mt1, solute carrier
family 25 member 17 (Slc25a17), tribbles homolog 2 (Trib2), zinc
finger protein 672 (Zfp672) and Stx3, differential expression could
be demonstrated irrespective of sex in HAB vs. LAB mice.
Differential expression of Ttr in the BLA could not be
confirmed, in contrast to Syt4, where qPCR (Fig. 2B) and in situ
hybridization (Fig. 2C) detected significantly higher expression in
the PVN, CeA and BLA of HAB compared to LAB mice.
Sequencing
We used sequencing to identify possible molecular correlates of
differences in gene expression between HAB and LAB mice.
Analysis of the HAB and LAB Mt1 locus failed to reveal any
genetic differences. In contrast, many polymorphic loci were
Cathepsin B: A Novel Candidate Gene for Anxiety
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identified at the Ctsb locus. Here, we found 76 SNPs, eight
insertions and nine deletions in HAB vs. LAB mice (defining
insertion and deletion relative to the mouse strain C57BL/6J). In
the promoter region, ten SNPs and two insertions were found. In
these ten exons, eight polymorphic sites (all SNPs) were identified
(Fig. 3). The vast majority of variations were found in the introns
and the downstream enhancer region (Table S3). Interestingly,
about six variations are located within a single 230 bp sequence
(between 22,269 and 22,045 bp in the promoter). A similar
density of polymorphic sites was found in the third and fourth
intron, where 18 variations were found in a 550 bp sequence, and
12 additional variations were found in another 400 bp sequence.
Additionally, condensation of twelve variable sites could be
identified in the downstream enhancer region (at a length of
350 bp).
Sequencing of the primer binding sites of the genes we analyzed
with qPCR did not reveal any polymorphisms, thus validating the
qPCR results. The identified SNPs in the respective sequences are
summarized in Table S2. Notably, the ones in Hmgn3 cause amino
acid substitutions.
Behavioral testing of KO mice
We could not identify any significant differences in bodyweight
between the Ctsb+/+ wildtype (WT), Ctsb+/2 heterozygous (HET)
and their Ctsb2/2 KO littermates, for both male and female mice
(data not shown). The average weight difference between male and
female mice was 5–6 g.
With respect to locomotion, there were no significant differences
between any of the groups, as measured with the EPM (all arm
entries, distance traveled) and the open field (OF; distance
Figure 1. Gene expression profiles of HAB vs. LAB mice in multiple brain regions. (A) gene expression confirmed by quantitative PCR and
(B) as detected by microarray-based gene expression analysis. N = 6–10 per group. Data are presented as means and for (A) +SEM; T p,0.1, * p,0.05,
** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0023604.g001
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traveled; Fig. 4A and B). None of the other parameters assessed on
the EPM revealed significant differences (data not shown). The
data obtained from the TST were not suitable for analysis – all
groups showed climbing behavior, so an evaluation regarding
immobility parameters was not possible. In the OF, the different
groups of male mice failed to show significant differences in the
Figure 2. Region-specific gene expression in HAB vs. LAB mice. Expression (A) of Syntaxin3 (Stx3) in the basolateral amygdala (BLA) and (B) of
synaptotagmin 4 (Syt4) in the BLA, the central amygdala (CeA) and the hypothalamic paraventricular nucleus (PVN) as measured by quantitative PCR
and (C) Syt4 quantified from in situ hybridization. Data are presented as means +SEM; T p,0.1, * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0023604.g002
Figure 3. Cathepsin B (Ctsb) gene sequence of HAB vs. LAB mice. Polymorphic sites are shown with positions in the coding sequence
referenced to the transcription start in the spliced mRNA in bp. Exons and untranslated regions (UTRs) are indicated by boxes (exons shaded, UTRs
completely filled black or white).
doi:10.1371/journal.pone.0023604.g003
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anxiety parameters (Fig. 4C), but female Ctsb KO mice showed a
significantly decreased inner vs. outer zone path length ratio
(Fig. 4D), combined with a decreased time spent with path length
in the inner zone of the test field, reaching a statistical trend
(Kruskal-Wallis H test – KWH: p,0.1, corrected Mann-Whitney
U test – MWU: p,0.1 only for the WT vs. KO comparison; mean
time spent in the inner zone 6 SEM for KO: 7.661.0 s, HET:
11.561.2 s, WT: 13.061.7 s; mean path traveled in the inner
zone 6 SEM for KO: 1.260.2 m, HET: 1.860.2 m, WT:
1.960.2 m).
In male mice, a trend towards decreased exploratory drive,
increased self-grooming and increased arousal was observed on the
elevated platform (EPF), as also indicated by the increased gut
activity in the Ctsb KO males compared to wildtype mice (KWH:
p,0.1; mean grooming frequency6SEM for KO: 1.660.3, HET:
2.760.5, WT: 1.460.5; mean frequency of exploratory head-
dips6SEM for KO: 30.862.8, HET: 43.163.6, WT: 35.861.9;
mean frequency of defecation6SEM for KO: 4.460.6, HET:
3.160.5, WT: 2.560.5). Female mice did not show any significant
difference.
Also, no differences were observed after stress exposure in the
stress-reactivity test (SRT; data not shown).
Although no significant differences could be observed between
WT and KO male mice (Fig. 4E) in the FST, several parameters
showed significant differences when comparing female mice.
Reduced swimming time indicated a less active coping strategy of
Ctsb KO mice (Fig. 4F). A statistical trend was observed for the
time spent floating in the same direction (KWH: p,0.1, corrected
MWU: p,0.1 for the WT vs. KO and HET vs. WT comparisons;
mean time floating6SEM for KO: 24466.2s, HET: 24164.8 s,
WT: 215611.1 s).
Discussion
By comparing the HAB vs. LAB transcriptomes using micro-
array-based gene expression profiling, we succeeded in identifying
32 candidate genes that were consistently differently expressed
between the two mouse lines. After validation of the results by
qPCR, we focused on genetic variations between the two lines in
the validated genes, and were able to identify about 90 variations
within the Ctsb gene, in contrast to the Mt1 gene, where no
polymorphisms were identified. Although none of the observed
SNPs in the coding sequence caused changes in the amino acid-
coding triplets, they can induce changes in mRNA stability.
Finally, by testing Ctsb KO mice and their wildtype littermates, we
could demonstrate that the KO and HET alleles resulted in
modestly increased anxiety-related behavior in female mice, in
accordance with the decreased expression in HAB mice. Similarly,
the CtsbKO and HET alleles had a robust effect on depression-like
behavior in the FST. Thus, our data support the hypothesis that
Ctsb influences depression-like behavior in HAB mice.
The differential expression of 16 genes could be confirmed, even
partially independent of gender. This increases our interest in the
corresponding candidate genes for anxiety, as both males and
Figure 4. Phenotypes of Cathepsin B (Ctsb) knockout (KO) vs. heterozygous (HET) and wildtype (WT) mice. (A) Locomotion of male and
(B) female mice in the open field, (C) anxiety-related behavior of male and (D) female mice as measured in the open field; (E) depression-like behavior
of male and (F) female mice as reflected by the forced swim test. Data are presented as means +SEM; * p,0.05.
doi:10.1371/journal.pone.0023604.g004
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females of each mouse line display the line-specific phenotypes.
The candidate genes for which differential expression in the entire
brain was confirmed are: Ctsb, Coro7, Mmp15, Slc25a17, Zfp672,
Abca2, Enpp5, high mobility group nucleosomal binding domain 3
(Hmgn3) and pyruvate dehydrogenase beta (Pdhb), Mt1, Stx3,
Mbnl1 and Trib2. Syt4, Tmem132d and Avp were also confirmed by
qPCR (the latter two have been described before [16,20]), though
their differential expression was restricted to specific brain areas.
We could reproduce about 50% of our gene expression levels
results through microarray analysis, which seems to be acceptable,
although hypotheses of region-specific gene expression differences
cannot be excluded for the genes not validated.
Regarding the identified candidate genes, other studies using
KO strategies have already shown that Abca2 and Syt4 make
significant contributions to phenotypes closely related to the
endophenotypes we focus on. Abca2 KO mice showed a decrease
in body weight and decreased locomotor abilities, as well as an
increased susceptibility to environmental stress [22]. The last point
especially suggests parallels to LAB mice, as qPCR also confirmed
that the LAB mice only expressed ,20% of the Abca2 mRNA
when compared to HAB mice.
Synaptotagmins, which comprise a large family of proteins that
regulate vesicle trafficking in neurons, are widely considered the
presynaptic ‘‘calcium sensor’’ in neuronal exocytosis [23,24,25],
and are highly evolutionary conserved. Syt4 KO mice, in
comparison to WT animals, showed reduced anxiety- and
depression-like behaviors in various tests, as well as enhanced
locomotion in the OF [26]. This finding supports results obtained
from our HAB and LAB mice, which showed increased expression
of this gene in the CeA, BLA and the PVN of HAB mice. Thus, it
appears likely that Syt4 contributes to the behavioral differences
observed in our animal model, and it has to be considered as
another candidate gene, which might influence emotionality
[25,27,28,29].
The Coro7 gene transcript and its protein have been shown to be
important in brain development [30,31]. Mmp15 and its gene
product are not well characterized with respect to brain functions,
but they seem to play a role in inflammation- and oncogenesis-
related processes [32,33]. Slc25a17 is a peroxisomal ATP
transporter [34], which makes this candidate gene an interesting
player in neurometabolism. The zinc finger protein Zfp672 is a
putative transcription factor that has been identified as differen-
tially expressed between HAB and LAB mice. Similarly, Hmgn3
was found to be 2-fold overexpressed in HAB relative to LAB
mice. The two SNPs identified (rs13474367 and rs13474366) are
non-synonymous coding. The first one – in all known transcript
variants – represents a substitution of serine in HAB by proline in
LAB mice, while the second one would only affect the amino acid
sequence derived from two transcript variants, changing glutamic
acid to lysine in LAB mice. Generally, HMGN family proteins
significantly contribute to the differential expression of many genes
[35]. Pdhb deficiency caused by mutations has been found to cause
severe damage to amino acid neurometabolism in humans [36].
Darios and Davletov [37] described the importance of Stx3,
which encodes a membrane protein required for neurite growth
and neural development as an activator of SNARE complexes.
Arachidonic acid also plays an important role in STX3 action,
highlighting the impact of metabolism as a potential cofactor
fundamental to neurometabolism, and therefore brain function
[37]. In HAB vs. LAB mice, expression differences in Stx3 have
been identified, again pointing to basic differences in neuronal
function between the two mouse lines (as also demonstrated here
by Syt4, Pdhb and Slc25a17), which have the potential to cause the
observed phenotypic differences.
Enpp5 encodes a nucleotide-metabolizing ecto-enzyme, a class
of enzymes that regulate the availability of extracellular nucleo-
tides, and therefore control signaling through purinoceptors such
as the P2X ion channels. Interestingly, one P2X ion channel
(P2RX7) has been identified by a number of studies as having
polymorphic sites (SNPs), which are associated with bipolar
disorder and major depressive disorder in a large number of
patients [38,39,40,41]. Thus, P2RX7 or a modulator of its
substrate, Enpp5, could be interesting novel targets for therapeutic
intervention.
It has been demonstrated that neurodegenerative diseases, as
well as metabolic stress, enhance the expression of Mt1 in
perivascular regions of the cerebral cortex, predominantly in
astrocytes [42]. Further experiments highlighted a connection
between physical stress and increased Mt1 expression in a variety
of brain regions. Increased expression has also been observed upon
subcutaneous administration of steroid hormones [43,44]. Ac-
cordingly, Mt1 might play a key role in the HAB/LAB mouse
model, where, besides differential expression, an increased stress
response to physical stressors, i.e. an enhanced release of
corticosterone has been demonstrated in LAB mice [45].
Interestingly, we could not detect any polymorphisms in Mt1,
which points to causes other than genetic variations on the
expression level. Still, the effect of differential expression is
inherited, as the measured differences seem to be consistent over
generations and independent of gender.
The highlight of our transcriptome analysis, the lysosomal
cysteine peptidase Ctsb, is an abundant and ubiquitously expressed
member of the papain family C1, and contributes to the terminal
degradation of proteins in the lysosome. However, there is
increasing evidence that Ctsb has more specific functions in health
and disease. In particular, KO mice have demonstrated that Ctsb
plays a major role in pathological trypsinogen activation in the
early course of experimental pancreatitis, and contributes to TNF-
alpha induced hepatocyte apoptosis [46,47].
Of the members of the C1 family of cysteine peptidases, Ctsb is
by far the most abundant in the brain (compare http://www.
brain-map.org/). However, Ctsb KO mice do not show any
obvious, distinct neurological phenotype [21], which is potentially
due to compensation or even rescue of the KO by other family
members. This is supported by the finding that Ctsb and cathepsin
L (Ctsl) double KO mice exhibit severe brain damage, with
neuronal loss and brain atrophy, underscoring the important role
of Ctsb in brain physiology [48,49].
Our gene expression data, which show strongly increased
expression of Ctsb in LAB compared to HAB animals, and the
identification of many genetic variations in Ctsb between our lines,
make it an interesting candidate for further research into its role in
the expression of emotional behavior, which (to our knowledge)
has never been addressed in Ctsb KO mice before.
The polymorphisms we identified do not affect protein
structure, but could definitely affect either mRNA stability [50],
or the recruitability of transcription enhancing or repressing
factors [16,51,52]. Here, we demonstrated a pronounced effect of
Ctsb deficiency on anxiety- and depression-like behaviors in mice.
Although our major findings are restricted to female mice, we
could also find moderate signs of increased anxiety and decreased
explorative drive in male Ctsb-deficient animals. Grooming
frequency on the EPF was higher in the HET group compared
to both KO and WT mice, pointing to more displacement activity,
i.e. arousal. Similarly, the frequency of explorative head-dips was
lower in these animals, indicating that the effects of Ctsb deficiency
can also be observed in male mice. As already supported by other
KO studies [53], this modest effect could be compensated for by
Cathepsin B: A Novel Candidate Gene for Anxiety
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other factors (e.g., other cathepsins) in the complete KO mice.
Compared to male mice, females showed pronounced differences
on numerous measurements in the OF test and FST. These clearly
underline Ctsb deficiency as a cause of increased anxiety-related
and depression-like behaviors [46]. Similar results, regarding the
relationship of Ctsb with changes in the brain, have so far only
been shown in connection with the urokinase-type plasminogen
activator receptor that participates in the functioning, develop-
ment and disorders of the speech cortex, with a link to epilepsy
[54,55]. Another hint for the possible brain function of Ctsb is that
its murine and human variants have similar biochemical
properties, and participate in the production of b-amyloid
peptides. Thus, lower levels of Ctsb could have both neurotoxic
and, under certain conditions, neuroprotective effects by causing a
decrease in the amounts of b-amyloid peptides [56,57,58].
There are many possible reasons for detecting these pronounced
differences in female mice only. First of all, the different hormonal
constitution might lead to a more distinct effect of Ctsb deficiency
in males and females. Compensatory action of other gene products
might also be more or less effective in different genders, a view
which is supported by evidence that these hormones regulate
cathepsins [59]. Sexual dimorphism also affects the normal
concentrations of corticosterone in mice and rats and cortisol in
humans, respectively. Nearly twice the concentration of cortico-
sterone can be observed in females compared to males [60], which
could imply a dimorphism caused by different sensitization of
receptor mechanisms. Other prominent sexual dimorphisms
include the actions of estrogen and testosterone, and the different
effects of neuroimmunoendocrine processes [61]. These same
mechanisms might account for the differences we observe in
prevalence rates for both anxiety and depressive disorders. Most
clinical studies dealing with these disorders show that women seem
to be affected by them almost twice as frequently as men
[62,63,64], so differently pronounced action of single candidate
genes on specific endophenotypes could well be sex-specific.
Thus, in summary, we demonstrate the functional importance
of Ctsb in anxiety-related and depression-like behaviors using KO
mice. Our findings suggest that Ctsb, as well as the other genes we
identified as differentially expressed in HAB vs. LAB mice, are
likely to represent genetic underpinnings of anxiety- and
depression-related behaviors. Although our findings in KO vs.
HET and WT mice were restricted to female mice, they might
mirror sexual dimorphisms, and the multifactorial nature of
evolutionary old and well-conserved mechanisms regulating
anxiety- and depression-like phenotypes.
Materials and Methods
Animals and behavioral tests
All animals were kept in the animal facility of the Max Planck
Institute of Psychiatry, under standard housing conditions (room
temperature 2362uC, relative air humidity 6065%, 12 h/12 h
dark/light cycle with lights on at 7 am). Animals were kept in
groups of two to four per cage, with light levels not exceeding
100 Lux at any time. Mice from each line were selected from
generations G16-32, based on their anxiety-related behavior, as
measured by their performance on the EPM. The animals were
also tested with the TST [15] for 6 minutes to assess their
depression-like coping strategy. Through heterozygous breeding,
we created litters of mice containing both Ctsb deficient animals
and control (non-deficient) animals (sequences of genotyping
primers are available upon request). 42 male and 55 female mice
Ctsb KO, HET and their WT littermates [46,65] were tested for
locomotion and anxiety-related behavior in the EPM and OF tests
for 5 minutes, for depression-like behavior in the FST and TST
for 6 minutes each [15], and for stress hormone response to a
15 minute SRT as described by Touma et al. [60]. The OF test we
used had illumination of 10 Lux in the central part of the field. To
assess explorative behavior, an EPF test [66] was performed for
5 minutes. The apparatus we used for this test consisted of a
centered platform of grey polyvinylchloride 40 cm high and 10 cm
in diameter, mounted to a wooden plate (42642 cm) and
surrounded by three wooden walls (w6h: 42658 cm), and left
open at the front for observation. The metrics we assessed on the
EPF test were the frequency and duration of rearings, the delay
before the first rearing, and the frequency of exploratory head-dips
over the platform edge and the frequency of grooming behavior,
which are indicative of displacement activity.
Testing was started on the Ctsb KO mice and their littermates at
the age of eight weeks, starting with the EPM test on day 1, and
continuing to TST on day 3, OF on day 7, EPF on day 9, SRT on
day 11, and FST on day 14. All of the behavioral tests were
digitally recorded or video-taped. The results of the EPM test, FST
and TST were analyzed as in previous studies [15,16]. The same
evaluation scheme was applied to the EPF test, by counting the
frequency of head-dips when mice reached the platform’s edge
with their shoulder line, the frequency, latency and duration of
rearing, and the frequency of grooming behavior. The OF tests
were analyzed using Anymaze v. 4.71 (Stoelting&Co., Wood Dale,
IL). The order in which the mice were tested was random, and
evaluation was performed by a trained observer who was not
aware of the lines of the mice. All chemicals and reagents not
declared otherwise were purchased from Sigma-Aldrich (Tauf-
kirchen, Germany).
Ethics statement
The government of Upper Bavaria (Oberbayern) approved our
animal experiments (approvals IDs – AZ: 55.2-1-54-2531-64-07
and 55.2-1-54-2531-73-02), which were conducted according to
the current regulations for animal experimentation in Germany
and the European Union (European Communities Council
Directive 86/609/EEC).
Tissue dissection by micropunching
Animals were anesthetized and killed by decapitation at the age
of ten weeks, three days after the TST. For MPIP24k gene
expression analysis, six male HAB and LAB mice from breeding
generation 16 were used, while for subsequent qPCR analysis, we
used eight female HAB, LAB and CD1 mice from generation 22.
A further group of eight male mice from each line, from
generation 29, was used for micropuncture. The brains of the
mice were collected, dissected into 200 mm slices, and mounted
from rostral to caudal to Superfrost microscope slides (Menzel,
Braunschweig, Germany) in a cryostat (Microm MH50, Microm,
Walldorf, Germany). The brain areas of interest were acquired
from these slices by micropuncture, through a method described in
previous studies [67], utilizing punchers with a diameter of 0.5 and
1 mm (Fine Science Tools, Heidelberg, Germany). The brain
regions collected included the Cg, the NAc core and shell, the
PVN, the SON, and the BLA, CeA and medial amygdala (MeA).
Punches of 1 mm diameter were collected from bregma +1.3 mm
to +0.9 mm, twice sampling the tissue medially about 0.5 mm
from the dorsal tissue border to receive the Cg, and bilaterally
sampling the NAc core, which inevitably included a minor part of
its shell around the anterior commissure. Further tissue was
collected medially 0.8 mm above the ventral tissue limit
(Ø=1 mm), and bilateral-dorsolaterally from the optic tract
(Ø=0.5 mm), to acquire tissue from the PVN and SON, from
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bregma 20.56 mm to 20.96 mm. Amygdala tissue samples were
collected bilaterally from two slides for each region with 1 mm
diameter punches. CeA was collected from bregma 20.96 mm to
21.36 mm dorsomedially from the ventral end of the external
capsule, MeA from 21.16 mm to 21.56 mm dorsolaterally from
the optic tract, and BLA/LA was collected from bregma
21.36 mm to 21.76 mm from in between the bifurcation of the
external capsule. All coordinates were based on the Mouse Brain
Atlas [68].
Tissue laser microdissection
Six male HAB, six male NAB, and six male LAB animals from
generation 25 were sacrificed using the previous procedure, except
for obtaining 25 mm slices in the cryostat (Microm). Only brain
slices containing the brain areas of interest were sampled,
including the anterior part of the Cg, the PVN, the SON, the
anterior DG, the CeA, and the BLA. For the DG, the same
coordinates as for the PVN and SON were used. To cover the
whole area of interest, an overall depth of 400 mm per region was
chosen. After sampling the Cg, BLA and CeA brain regions, four
brain slices were mounted onto an LMD6000 metallic frame slide,
which was covered with a membrane of polyethylene terephthalate
(Leica Microsystems Deutschland, Bensheim, Germany), while the
following four slices were mounted onto Superfrost slides (Menzel).
This procedure was repeated for the next eight slices. For the
region containing the PVN, SON and DG, only the first two slices
were mounted to the LMD6000 frame, with the next two mounted
to the Superfrost slides, and so on, again alternating between
them. Only the LMD6000 slides were used for further processing,
and these slides were stored at 280uC. Before we performed laser-
microdissection, the brain slices on the LMD6000 frame slides
were stained with cresyl violet. Our staining protocol started with
staining the slides for 90 seconds in cresyl violet, followed by
washing them in 70% and 96% ethanol for 20 seconds each, and
finally washing them in isopropanol for 5 minutes. The slides were
refrozen after staining, and were then processed with the laser-
microdissection microscope (AS LMD, Leica). For dissecting these
brain areas, we chose a magnification of 1006, laser power
between 80–100%, and speed varying between 1 and 4. Cut-out
brain areas were stored in the caps of 0.2 ml PCR soft tubes
(Biozym Scientific, Hessisch Oldendorf, Germany), and were
cooled with dry ice immediately after the completion of one brain
region.
Total RNA isolation and amplification
Total RNA was extracted in presterilized 1.5 ml safelock tubes
(Eppendorf, Hamburg, Germany), using a standard TRIzol
(Invitrogen, Karlsruhe, Germany) chloroform protocol. After the
sample tissue was homogenized by adding 300 ml TRIzol with a
pipette, 1 ml linear acrylamide (5 mg/ml, Ambion, Austin, TX)
and 60 ml chloroform (Carl Roth, Karlsruhe, Germany) were
added, and the samples were vortexed. This was followed by
centrifugation for 5 min at 18uC and 13,000 rpm. The RNA was
then precipitated by applying 180 ml isopropanol (Carl Roth)
overnight at 220uC, centrifuging the sample at 4uC and
13,000 rpm for 30 min, and then washing it twice in 500 ml
70% ethanol (Carl Roth), with ten-minute centrifugation steps at
4uC and 13,000 rpm in between. After the last centrifugation step,
all remaining liquid was removed with a pipette, and the pellets
were dried in an incubator for 15 min at 45uC and stored solved
in 13 ml of water (Ampuwa, Braun Melsungen, Melsungen,
Germany).
For the MPIP24k experiment, the total RNA we extracted was
amplified and dye-coupled in two rounds, using Ambion’s Amino
Allyl MessageAmp aRNA kit (Ambion). T7 oligo(dT) primers were
used for the first round of reverse transcription to select specifically
for mRNA, and random hexamer primers were used for the
second round of reverse transcription.
For the Illumina MouseWG-6 experiment, the RNA was
amplified using the Illumina TotalPrep RNA Amplification kit
(Ambion). 5 mg of material per sample was required for loading the
microarray slides. We ensured correct quantification by measuring
optic density in a NanoPhotometer (Implen, Munich, Germany),
and through additional analysis on agarose gel. Samples not
fulfilling all of our homogeneity criteria (samples with inadequate
concentrations or size distribution) were excluded from further
analysis.
Hybridization and quantification of the MPIP24k arrays
Ten array slides per brain region (MPIP24k arrays containing
24,192 probes, MPI of Psychiatry, Munich, Germany [69,70],
platform available in NCBI/GEO with accession number:
GPL7467; http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc
=GPL7467) – serving as technical replicates - were prehybridized
prior to the experiment in a prehybridization buffer, for 1 h at
42uC. The buffer consisted of 125 ml formamide, 62.5 ml
206SSC, 2.5 ml 10% SDS, 2.5 ml BSA at 10 mg/ml and
57.5 ml of water. The array slides were then washed in water
and isopropanol, and dried by three minutes of centrifugation
(Megafuge 1.0R, Heraeus, Hanau, Germany) in 50 ml tubes at
1500 g (Sarstedt). Dye-coupled aRNA samples were mixed with
the opposite dye-coupled samples of the relevant regions from the
other mouse line, and were loaded with a hybridization buffer
(consisting of 500 ml formamide, 250 ml 206SSC, 10 ml 10% SDS,
5 ml mouse-COT1-DNA at 20 mg/ml (Invitrogen) and 40 ml poly
adenylic acid at 2.5 mg/ml (Amersham Biosciences) to five arrays
each under m-Series LifterSlips (Menzel). All arrays were
hybridized at 50uC for 16–17 h in separate hybridization
chambers. The arrays were then washed in 26SSC and 0.1%
SDS for 5 minutes at 42uC, for 10 min at room temperature in
0.16SSC and 0.1% SDS, four times in 0.16SSC for 1 min each,
and finally for 20 s in 0.016SSC solutions. The slides were dried
by three minutes of centrifugation at 1,500 rpm. Then, the arrays
were scanned on a PerkinElmer ScanArray 4000 (PerkinElmer
Life and Analytical Sciences, Shelton, CT) laser scanner, using
automatic focusing and laser power between 60 and 80 for Cy3,
and 40 and 70 for Cy5. This ensured that, on average, the same
fluorescence intensities were reached in both dyes, and that not
more than 1–2% of spots had fluorescence intensities above the
saturation point. Quantification of all array data was performed
with QuantArray software (GSI Lumonics, Billerica, MA), by
applying a fixed-circle quantification protocol, with manual
positioning of all grids over the hybridized spots. To provide a
negative control for the hybridization and evaluation procedure,
excess aRNA was used for an additional hybridization in both Cy3
and Cy5 combinations.
Hybridization and quantification of the Illumina
MouseWG-6 arrays
The platform description is available at NCBI GEO, accession
Number GPL4234 (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?token=fjqlzekgyecycng&acc=GPL4234). Each microarray
slide had the capacity for six samples. Samples containing the
same brain regions were hybridized in the same batch, so a
maximum of six individual mice of each breeding line were
compared per batch. Reagents and material for the analysis were
provided by Illumina. In brief, each sample was mixed with
hybridization buffer and loaded onto the designated array field,
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and the slides were then put into hybridization chambers and
incubated for 17 h in Illumina incubation chambers. The arrays
were washed in several steps, incubated with Cy3-Streptavidin,
again washed several times, and dried by centrifugation. Finally,
data on fluorescence was gathered using a BeadStation scanner
(Illumina), and analyzed with the BeadStudio (Illumina) software.
The manufacturer’s built-in controls were also analyzed, including
hybridization controls and sample dependent parameters. Only
microarrays meeting Illumina’s recommended quality control
criteria were used for further evaluation.
Quantitative PCR (qPCR)
Candidate genes were selected for further analysis if they
showed at least 40% greater regulation in one region, and at least
30% greater regulation in all other regions, in HAB mice relative
to LAB mice, with adjusted p-value,0.05.
Three 200 mm coronal sections were also taken at different
brain levels, for representative whole brain analyses. A maximum
of 1 mg of total RNA was reverse transcribed with Superscript II
(Invitrogen, Karlsruhe, Germany) after DNAse treatment. For
quality control, a small aliquot of each cDNA was analyzed on an
agarose gel. cDNA of male or female HAB or LAB mice was
analyzed by qPCR, using the QuantiFast SYBR Green PCR Kit
(Qiagen, Hilden, Germany). The oligonucleotide primers were
designed based on the Primer3 algorithm [71], and were then
purchased from Sigma-Aldrich. We selected gene products for
quantification by qPCR if they showed: significant expression
differences between HAB and LAB mice with an adjusted p-value
of ,0.10, at least 30% greater regulation between lines, and
differential expression in the microarray experiment in all, or at
least three, analyzed regions. All the primers we used for qPCR
are listed in Table S1. Experiments were performed in duplicates
on the LightcyclerH2.0 instrument (Roche Diagnostics, Mann-
heim, Germany) using the following PCR process: initial
denaturation at 95uC for 10 min, followed by 40 cycles of
denaturation (95uC for 10 s), and then a combined annealing and
extension phase (60uC for 30 s). At the end of every run, a melting
curve (50–95uC with 0.1uC/s) was used to ensure the quality of the
PCR product. Crossing points (Cp) were calculated with Light-
CyclerH 4.0 software (Roche Diagnostics), using the absolute
quantification fit points method. The threshold and noise band
were set to the same level in all compared runs. Relative gene
expression was determined by the 22DDCT method [72]. Cp were
normalized to the housekeeping genes Gapdh, Hprt1, Atp2b1,
Rpl13a and Polr2b, or any combination of two of the mentioned
genes. Fold regulation values were calculated relative to the
expression mean of the group displaying the lowest expression.
In situ hybridization (ISH)
ISH using 35S-UTP labeled ribonucleotide probes was performed
as described in previous studies [73,74] to detect Syt4 mRNA.
Briefly, sets of sections for each riboprobe ISH were fixed in 4%
paraformaldehyde, and acetylated in 0.25% acetic anhydride in
0.1 M triethanolamine/HCl. Afterwards, the slides were dehydrat-
ed with progressively higher ethanol concentrations, degreased with
chloroform, rinsed in ethanol and then air dried. The antisense
cRNA probe for Syt4 (470 bp) was transcribed from a linearized
plasmid, and labeled using SP6 polymerase transcription systems,
using a standard labeling reaction mixture consisting of 1.5 mg of
linearized plasmid, 16 transcription buffer, 0.12mCi of 35S-UTP,
1 mMdNTPs, 16.7 mMDTT, 40 U of RNAse inhibitor, and 20 U
of the polymerase. The reaction mix was incubated at 37uC for
three hours, and the labeled probe was then separated from free
nucleotides with spin columns (Qiagen, [74]). The tissue sections (5
sections per slide) were saturated with 100 ml of hybridization buffer
(Tris HCl, EDTA, NaCl, formamide, 5 M DTT, Dehnhard’s
solution, DEPC H20, 50% dextran sulfate) containing 106 cpm
35S
labeled riboprobe. Brain sections were coverslipped and incubated
in humid chambers for 18–22 h, at a temperature of 55uC. After
this was done, the slides were rinsed in 26SSC, treated with RNAse
A (20 mg/l), washed in progressively less concentrated SSC
solutions, dehydrated by progressively more concentrated ethanol
solutions, and air-dried, before they were photographed with Kodak
BioMaxMR films (Amersham, Braunschweig, Germany) over a 14-
day period. Afterwards, the films were fixed, developed, and
digitized, and the radiation-induced blackening of different brain
regions was quantified by image analysis, using Scion Image
(Version 4.0.3.2, Scion Corporation, Frederick, MD) software.
Autoradiograms were analyzed by computer assisted optical density
readings (relative grey intensity as a measure of relative expression)
of the respective area, as well as the relative size of the labeled area.
Three to six brain sections of each individual were quantified by an
observer unaware of the individual’s breeding line, and the highest
expression (hybridization signal of a certain region, minus the
background signal of a nearby structure that does not express the
gene of interest) was used to calculate each mRNA expression,
respectively.
Sequencing of candidate genes
To identify polymorphic sites between the HAB and LAB mice,
the Ctsb and metallothionein 1 (Mt1) coding genes were sequenced,
as these were the two candidate genes whose involvement in
diverse molecular pathways was best described. In both cases,
about 2,500 bp of the gene promoter, all exons and introns (if the
latter did not exceed 2,000 bp), and about 2,000 bp of the
downstream enhancer regions (DER) were sequenced. Sequencing
primers were designed to cover 500 to 600 bp.
Sequencing was also used to verify qPCR reaction products,
and their primer binding sites. In this case, the fragments used
were between 200 and 500 bp.
DNA was isolated from tail tips using the NucleoSpin Tissue
(Macherey-Nagel) kit, from fresh fecal samples as described by
Murgatroyd et al. [75], or sequencing was prepared based on
cDNA. PCR reactions were set up in three HAB and three LAB
samples. The primers we used are summarized in Table S4. All
amplifications were carried out using Taq polymerase (Fermentas,
St. Leon-Rot, Germany) in 25-ml reactions with the following
procedure: initial denaturation at 94uC for 4 mins, 40 cycles of
denaturation (94uC for 1 min each), annealing (52–66uC for
1 min) and extension (72uC for 1 min), followed by 10 min of final
extension at 72uC. 15–20 ml of PCR or qPCR product were
purified by washing the sample twice with nuclease-free water,
using the NucleoFast 96 PCR Clean-up kit (Macherey-Nagel).
Clean-up plates were centrifuged at 9uC and 4,500 g for 10 min
(Heraeus Multifuge 4KR, Thermo Fisher Scientific, Waltham,
MA), and resolved for ten more minutes in 25 ml of water on a
shaker (Eppendorf). 2.4 ml of cleaned up PCR product was used
for the sequencing reaction (BigDye Terminator Kit, Applied
Biosystems, Foster City, CA), with 1.2 ml of sequencing buffer,
0.4 ml BigDye reagent and 1 ml of the forward primer per sample.
If sequencing reaction results were unclear or unreadable, the
sequencing reaction was also performed with the reverse primer.
Sequencing reactions were set up on ThermoFast 96 PCR plates
(ABgene, Hamburg, Germany) using a PTC-225 Gradient Multi-
Cycler (MJ Research, Miami, FL) using the following procedure:
initial denaturation at 96uC for 1 min, 35 cycles of denaturation
(96uC for 10 s), annealing (50uC for 5 s), and finally extension
(60uC for 4 min). Sequencing reaction products were purified by
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washing them twice in 20 ml injection solution, using Montage
SEQ96 plates (Millipore, Billerica, MA) on a vacuum pump
(Biomek 2000 Laboratory Automation Workstation, Beckman
Coulter, Fullerton, CA), and the reaction products were then
transferred to 96 well plates. Sequences were determined by
capillary electrophoresis on a 3730 DNA Analyzer (Applied
Biosystems) at the HelmholtzZentrum’s Institute of Human
Genetics (Neuherberg, Germany). Sequence analysis and com-
parison were done using FinchTV Ver. 1.2 (Geospiza, Seattle,
WA) and BioEdit Ver. 7.0.2 (Tom Hall, Ibis Biosciences,
Carlsbad, CA) softwares.
Statistical analysis
All data, except for data from high throughput gene expression
profiling, was analyzed using SPSS Ver. 16.0.1 (Chicago, IL). The
Kruskal-Wallis test (KWH) was used for comparisons over more
than two groups, with subsequent Mann-Whitney tests (MWU), as
well as sequential Bonferroni correction for multiple testing (if
applicable).
For statistical evaluation of the MPIP24k arrays, analytic
methods were applied as described in previous studies [76,77]. In
brief, an MA-plot was first generated to display the raw fluorescence
intensities of Cy5 (R) and Cy3 (G), with M= log2 R/G and A= log2
ffiffiffiffiffiffiffi
RG
p
. The data were then normalized to exclude systematic and
technical errors. The data were first normalized twice, by
subtracting a function c from the logarithms of the fluorescence
intensities (log2 R and log2 G). First, a global normalization was
performed, based on the assumption that R and G correlate:
log2
R
G
[log2
R
G
{c~log2
R
kG
:
In the second normalization step, an intensity-dependent normal-
ization was added, which was done by applying a LOESS smooth
operation, as described in the R software package (http://www.
r-project.org). This was calculated with:
log2
R
G
[log2
R
G
{c(A)~log2
R
k(A)G
,
where c(A) stands for the LOESS smooth of the MA-plot. 40% of
the values in the MA-plot were used to calculate the LOESS
smooth. In several subsequent normalization steps, we minimized
differences that resulted from an unequal distribution of probes in
the array production, or from unbalanced fluorescence intensities
within one array slide. All data were then merged into a matrix. P-
values for multiple testing were calculated by permutation, and are
therefore called adjusted p-values.
For the Illumina Mouse WG arrays, Illumina BeadStudio gene
expression results were analyzed using a statistical procedure
similar to the one for the MPIP24k experiment. All analyses were
performed using R-packages, based on ‘beadarray’ described by
Dunning et al. [78], which simplifies comparisons between high
numbers of arrays. First, pair-wise box plots were generated to
compare the mean amount of expression within each line and
brain region. Normalization for expression values was applied to
all samples with the ‘QSpline’ function. Clustering using the
‘hclust’ function shows that each brain region per line shows
similar expression patterns. Three samples from different brain
regions were identified as inadequate during the scan process, and
have therefore been excluded from further analysis. For
differential expression analysis, the functions of the ‘limma’
package were applied to log2-transformed values. The resulting
matrix has been used for all subsequent analyses. Significantly
regulated genes were ranked using an empirical BAYES method,
as implemented in the limma R-package [79,80].
Supporting Information
Table S1 List of primers for qPCR with chromosomes and
exons the primers hybridized to. List is sorted alphabetically
according to the gene symbols. Candidate genes from the gene
expression microarray experiment are marked by asterisk after the
gene symbols, all others were used as housekeeping genes.
(DOC)
Table S2 Variations identified in or around the amplified
fragments used in qPCR. Variation type refers to single nucleotide
polymorphisms (SNPs), deletions or insertions, the genomic
position to the physical position on the respective chromosome
(Mouse Genome Build 37), HAB and LAB to their line-specific
allele, location in the gene to the functional structure of the
variation locus, relative (rel.) position to the gene locus, position in
mRNA to the spliced mRNA and SNP identifier to already
described polymorphisms.
(DOC)
Table S3 Variations identified in the cathepsin B (Ctsb) gene.
Variation type refers to single nucleotide polymorphisms (SNPs),
deletions or insertions, the genomic position to the physical position
on chromosome 14 (Mouse Genome Build 37), HAB and LAB to
their line specific allele, location in the gene to the functional structure
of the variation locus (downstream enhancer region: DER), relative
(rel.) position to the Ctsb locus, position in mRNA to the spliced
mRNA and SNP identifier to already described polymorphisms.
(DOC)
Table S4 Primer sequences used for sequencing of the cathepsin
B (Ctsb), metallothionein 1 (Mt1) genes as well as for the fragments
analyzed by qPCR including the PCR fragment length resulting
from each reaction.
(DOC)
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